Enterprise League logo
Inhalon Biopharma Logo

Inhalon Biopharma

Durham, United States (US) · Health and Medical

Do your work at Inhalon Biopharma?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Inhalon Biopharma is a Durham, North Carolina-based clinical-stage biotechnology company developing revolutionary inhaled antibody treatments for acute respiratory infections.

We are rapidly advancing programs for the treatment of multiple respiratory infections, including Respiratory Syncytial Virus (RSV), influenza, human metapneumovirus, and SARS-CoV-2. Because preventative vaccine therapies for acute respiratory infections fail to fully protect people from infection, Inhalon’s breakthrough technology has the potential to address a massive unmet need by treating active infection, directly in the lung.

Our core technology, ‘muco-trapping,’ utilizes engineered antibodies to capture pathogens within the lung mucus, effectively blocking their spread and facilitating their rapid elimination. This innovative approach represents a significant advancement in respiratory care, offering a simplified ‘test-to-treat’ model for patients.

Most teams do this before shortlisting


Contact Details

info@inhalon.com

Durham, United States (US)

Company Type

Private Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Inhalon Biopharma

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.